One of the key considerations for a new innovation centers on intellectual property (IP). This is the first part of a two-part mini-series on IP with an initial focus on technology transfer
The 2019 American Academy of Dermatology (AAD) Meeting in Washington, D.C., is always a wonderful reminder of all of the innovation happening in dermatology. I left the meeting optimistic that our field is moving forward with new disease insights, new therapies, and new diagnostics driven forward by motivated, talented individuals across academia and industry.
Biopharmaceutical companies and their partners are taking a page from Silicon Valley by sponsoring hackathons and competitions to drive innovation in research and develop new solutions for patients.
What exactly is digital health? The scope and definition of digital health is broadening and now, it seems, digital health is essentially anything that isn’t a drug or traditional medical device.
Successful innovation requires an intimate understanding of underlying unmet clinical needs.
Drs. Steve Xu and William Ju discuss the need for entrepreneurship education in medical school and residency training.
May 16, 2019
What you should know about technology transfer
Apr 04, 2019
Innovation dispatches from the AAD
Mar 19, 2019
Hacking the Biopharma Industry
Feb 01, 2019
Opportunities for collaboration with industry